TrialJournal of pain and symptom management2012

Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303).

Dorothy Romanus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.